RpexBio

RPEXBio is a biotechnology company focused on accelerating the development of biologics through its proprietary Rapid Protein Expression (RPEX) platform. The company specializes in the high-yield production of complex recombinant proteins, including viral antigens and monoclonal antibodies, which are critical for vaccines and therapeutics. Their technology is designed to significantly reduce the time required for protein expression and purification, facilitating faster responses to emerging infectious diseases. RPEXBio supports both internal drug discovery programs and provides specialized protein production services to academic and industrial partners.